Guardian Unlimited
Go to:  
Guardian UnlimitedThe Guardian
Home UK Business Online World dispatch The wrap Weblog Talk Search
The Guardian World News guide Arts Special reports Columnists Audio Help Quiz

UK news
  Search this site

  In this section
Huntley, accused of Soham murders, in intensive care after cell overdose

Girl, 5, dies after being swept up into sky by helium balloon as storm hits holiday crowd

Woodhill's bleak and lonely security cells

Brutal death of a travelling child

Man charged with 1984 killing

Out of the spotlight

Ready meals loaded with dangerous levels of salt, food agency warns

Seroxat warning over risk to young

Ulster police admit 2,000 murders will stay unsolved

The Doughnut, the less secretive weapon in the fight against international terrorism

In brief

Accusations, dates and appearances

Pub closure may end war of the puddings

Salford's terraces turned upside down

Crime writer's Pushkin steals 30,000 prize

Children who 'can't live without' constant TV

Hospital ban on 'stalking' father

Schools told to text parents of truants

'Lives at risk' as school arson bill tops 100m

School cuts classes to balance books

'British vulture' back from the brink

Body in boot, man arrested

Teenage burglars target projectors

New inspection of jail ordered

Reports implicate Ebbers in fraud

Ireland launches legal challenge to Sellafield

Prison van escapee surrenders

Seroxat warning over risk to young

Suicidal feelings may be side effect for under-18s

Sarah Boseley, health editor
Tuesday June 10, 2003
The Guardian

An unprecedented high-level warning will go out to doctors and patients today that Seroxat, the most commonly prescribed antidepressant in Britain, could cause young people under 18 to kill or harm themselves.

The warning from the head of the government's drug regulatory agency, is a blow to the pharmaceutical companies that manufacture antidepressants of the Seroxat class, which include Prozac.

An acknowledgement that one of these drugs can cause young people to feel suicidal will undermine the drug companies' repeated assertions that they have no such effect on adults. Last week the West Yorkshire coroner, sitting in Leeds, left open the possibility that Prozac "may or may not" have contributed to the suicide of librarian Wendy Hay.

The medicines and healthcare products regulatory agency (MHRA), which licences drugs in the UK, is expected to take a tough line with GlaxoSmithKline, the manufacturer of Seroxat, when it announces the warning today.

The agency takes the view that Glaxo should have drawn its attention earlier to clinical trials among children which showed that some suffered damaging side effects. Some of the young people on Seroxat became agitated, aggressive and suicidal, a trend that was not matched among similar young people given a placebo.

As with many other drugs, Seroxat does not have a licence for use in the under-18s, but doctors widely prescribe it.

The MHRA intends to send clinical auditors to look at all the data the company holds.

Yesterday Glaxo denied it had covered up studies suggesting the drug could do damage to the under-18s.

"We have made available all clinical and safety data from the paroxatine (Seroxat) paediatric studies in a timely manner," it said in a statement.

The data on the side effects of Seroxat on young people was sent to a review set up by the committee on the safety of medicines, whose experts advise the MHRA.

In February, the first working group investigating the safety of this class of drug - known as SSRIs (selective serotonin reuptake inhibitors) - was disbanded after revelations in the Guardian that some of the members had shareholdings in Glaxo. The group was recently re-formed.

Yesterday David Healy, the director of the North Wales department of psychological medicine at the University of Wales, who gave evidence to the group last year on the suicide risks for some who take SSRIs, said that if young people were at risk, so were adults.

"If there are cautions being put in place warning that the drug can cause problems for children, it is clear that warnings should be put in place for adults as well," he said.

Special reports
BSE crisis
Medicine and health

Interactive guides

Useful links
Ash (anti-smoking site)
British Medical Association
Department of Health
General Medical Council
Health on the Net Foundation
Institute of Cancer Research
Medical Research Council
NHS Direct
World Health Organisation

Printable version | Send it to a friend | Save story



Guardian Unlimited Guardian Newspapers Limited 2003